Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Loughborough, England, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
-
Tembo distribution partner network scale considerably expanded; additional agreements signed adding 5,000+ EV conversion kits to commitment and order book pipeline First version of next generation...
-
2022 Revenues of $1,401.2M, Gross Profit of $464.3M, ex-TAC Gross Profit of $569.6M, Net Loss of $12.0M, and Adjusted EBITDA of $156.7M were all around mid-point of guidance while Non-GAAP Net Income...
-
TORONTO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “company”) (TSX, NYSE:HBM) today released its fourth quarter and full year 2022 financial results and annual...
-
Record cash margin of $201.7 million Record operating cash flows from continuing operations of $175.1 million MONTRÉAL, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the...
-
VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (“Eldorado” or the “Company”) provides detailed 2023 production and cost guidance and five-year production...
-
Fiscal 2022 Revenues of $898.3 Million and Fourth Quarter 2022 Revenues of $249.3 Million Increased 10.7 Percent and 17.8 Percent over Fiscal Year and Fourth Quarter 2021 Revenues, Respectively ...
-
Resilient 2022 results for the Group, confirming the power of its omnichannel model and its operational agility Transformation of Fnac Darty into a major player, recognized for and committed to...
-
New York, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bioinformatics Global Market Report 2023" - https://www.reportlinker.com/p06229161/?utm_source=GNW ,...
-
Positive Phase 3 MAESTRO-NASH study results reported in December 2022 position Madrigal for a resmetirom new drug application filing in the first half of 2023Madrigal reports year end cash, cash...